All articles by Eoin Ryan

AIFA’s horizon scanning 2024 predictions suggest an influx of ATMPs

The mid-year period marks a significant phase for horizon scanning activities that map the regulatory approval progress of innovative medicines…
Patching the problem of EU drug shortages

The EU’s “Union list of critical medicines” stole many pharma-related headlines this week. Its publication is undoubtedly significant, but the…
EC’s proposed pharma reforms spark industry discontent

The recent legislative reform proposals put forward by the European Commission (EC) have sparked significant discontent among pharmaceutical companies. The…
Inflationary storm clouds will continue to buffet global pharma industry in 2023

While the threat of high inflation is receding, its second-round effects may not quickly abate. Pharma may have to navigate…
New dawn for the EU’s joint procurement crisis response

The European Union (EU) is on the cusp of approving clearer rules governing the joint procurement of medicines and medical…

How horizon scanning can help predict the future for EU’s Alzheimer’s disease market

Last year saw signs that the tide is beginning to turn for the approval of innovative Alzheimer’s disease (AD) medicines,…
Pharmaceutical and healthcare sectors jointly top global PMI ranking for first time

n an unusually pronounced trend, the IHS Markit Purchasing Managers Index (PMI)(tm) report for August reveals the global pharmaceutical and…
Industry hopes dashed after EU compromises to squeeze through cross border HTA agreement

The innovative pharmaceutical industry has emerged shaken following last week's compromise-driven agreement on joint scientific health technology assessments in the…
Unlocking biomarker diagnostics in Europe and the win-win for the innovative oncology sector

In the years to come, Europe is likely to reach an inflection point when it comes to which countries widen…
EU countries make inroads in COVID-19 vaccination race even as supply concerns linger

While daily news across Europe are filled with doom-and-gloom reports of delays in the roll-out of COVID-1 vaccines, the latest…